SKYE Skye Bioscience, Inc.

NASDAQ
$1.77

Skye Bioscience, Inc. (SKYE) is expected to report earnings on November 10, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -74.4% since its last earnings release on August 14, 2026.

Skye Bioscience Beat Consensus Estimates
Friday, August 14, 2026 · 9:33 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 9:35 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.77

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Skye Bioscience, Inc.

Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.